Key result
Pharmacological thromboprophylaxis in patients receiving epidural anesthesia requires individualized risk-benefit assessment due to the competing risks of venous thromboembolism and epidural hematoma.
No takes yet. Share an insight, caveat, or question.
This editorial emphasizes the importance of weighing the risks of epidural hematoma against the benefits of neuraxial anesthesia in surgical patients receiving pharmacological thromboprophylaxis.
Harsoor et al. (2012) conducted an editorial in Deep vein thrombosis and epidural hematoma in surgical patients. Pharmacological thromboprophylaxis and epidural anaesthesia was evaluated. Pharmacological thromboprophylaxis in patients receiving epidural anesthesia requires individualized risk-benefit assessment due to the competing risks of venous thromboembolism and epidural hematoma.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: